Showing posts with label Nuvaxovid. Show all posts
Showing posts with label Nuvaxovid. Show all posts

Nuvaxovid

Nuvaxovid SARS-CoV-2 rS with matrix M adjuvant NVX-CoV2373 was approved for the following therapeutic use. As at 31 May four case…
]]>